“Is ADHD really a disease? My wife says I’m just lazy.”
Patients ask the best questions.
My patient asked me this during an adult ADHD evaluation. He was a pretty typical patient. He had made his own diagnosis. He looked up the diagnostic criteria and realized that he fit ADHD to a tee. He came in to talk with a doctor about whether he really had ADHD. I fumbled through an explanation about the metaphysics of disease, and my patient interrupted me to ask, “So do I need Adderall?”
Patients ask the best questions.
Whether ADHD is a disease is a great question. This discussion starts with our lack of a consensus definition for disease. The best definition I can come up with is that a disease is a biological explanation for a patient’s symptoms.
In the case of ADHD, we have not identified a precise biological mechanism. There is no diagnostic blood test or MRI finding that confirms the diagnosis. We make the diagnosis with a subjective checklist of items such as losing your car keys or easily getting distracted. Patients usually come to my clinic already having made a self-diagnosis. I am not sure if ADHD is a disease. I am not even sure what a disease is. However, the practical question is whether the label helps us care for a patient.
There are many reasons to evaluate a patient for ADHD. Some patients learn that they do not have ADHD but are not sleeping enough. Others receive a diagnosis of ADHD and feel better just because they have an explanation for their symptoms. Overwhelmingly, the question in my clinic is whether patients need stimulants.
I appreciate the controversy around prescribing stimulants. On one hand, prescribing stimulants can make us seem like we are medicalizing the normal human condition and/or acting as pawns of Big Pharma. On the other hand, not prescribing them is undertreating a stigmatized condition. As always, the truth is probably somewhere in between.
What does the evidence say about stimulants?
A 2025 meta-analysis of over 100 RCTs summarizes the data. It reports a reproducible and clinically meaningful improvement in ADHD symptoms during the initial couple of months of treatment. Another meta-analysis tells us that cardiovascular harms are clinically insignificant increases in blood pressure and heart rate.
There is much less robust evidence for the long-term effects of stimulants. Few RCTs follow patients longer than a couple of months. The longest RCT found that stimulants continue to improve symptoms at 1 year. However, the primary outcome for this study was symptom score at 12 weeks, and over 40% of patients had dropped out at the 1-year mark. The most rigorous long-term safety study found a statistically significant increase in cardiovascular disease, although the odds ratio was <2. This study did not find an association between stimulants and arrhythmias, heart failure, thromboembolism, and ischemic heart disease. As with any observational study, there are likely to be confounding factors. For instance, patients with early cardiovascular side effects may stop the medication before developing clinically significant disease.
I generally tell my patients that the medication guidance is that the medications can provide benefit, especially in the first few months. While we do not have a complete understanding of the long-term effects on cardiovascular health, these risks are likely to be small. If patients meet the subjective diagnostic criteria for ADHD, whether or not to use medications is a perfect time for shared decision-making.
How severe are the symptoms?
Are you forgetting tasks at work that put you at risk of getting fired?
Do you constantly get into fights with your spouse because you aren’t keeping up with the laundry?
Would an “N-of-One Trial” make sense here?
After this sort of discussion, he decided to try a stimulant. When I saw him back at 4 weeks for follow-up, he was feeling a little more productive and was not having any side effects. We decided to continue the medication at the same dose. We will keep checking in to see if the medication continues to help.
At the end of our visit, I asked him if he thought ADHD was a disease. He wasn’t sure.
Ken Noguchi, MD, PhD, is a family medicine doctor and an assistant professor in the Department of Family Medicine and Community Health at the University of Wisconsin School of Medicine and Public Health.



Really appreciate your thoughts on the subject. Thank you for your time.